BRAF and neoplasm: Although melanoma tumour tissue is more often accessible, ctDNA can be used to quickly identify theranostic BRAF mutations, without going through the various preanalytical steps commonly performed on tumour tissue (formalin fixation, paraffin embedding, preparation of thick sections) [6].